The passage of the American Recovery and Reinvestment Act of 2009 provides enormous opportunities for biomedical research and the life sciences industry. The National Institutes of Health (NIH) received $10.4 billion in the Recovery Act, the majority of which will be used to either fund R01 applications that were reviewed last year and which scored well, but weren't funded, or to award supplements for existing NIH grants.

However, the NIH has published notices announcing two excellent opportunities to obtain Recovery Act funding for new scientific projects....

Please see full alert for more information.